BioWorld BioWorld MedTech BioWorld Asia BioWorld Science

BioWorld

OS Therapies heading to FDA with positive osteosarcoma data
With positive data in hand from its phase IIb trial testing immunotherapy candidate OST-HER2 in osteosarcoma, OS Therapies Inc. anticipates a regulatory filing this year...

More in BioWorld

BioWorld MedTech

Abbott closes Cardiomems coverage saga with Medicare win
The Medicare coverage story of the Cardiomems device has a Homeric air about it, spanning nearly a decade starting with an adverse local coverage determination in 2016....

More in BioWorld MedTech

BioWorld Science

Commission proposes ‘radical overhaul’ of obesity definition, diagnosis
A global commission has proposed a fundamental change to the way obesity is defined and diagnosed. If the change is implemented, obesity would be considered a health risk...

More in BioWorld Science

BioWorld Asia

Abbvie and Simcere enter a $1B T-cell engager deal
Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare Conference...

More in BioWorld Asia

BioWorld Insider Podcast

The BioWorld Insider podcast is a monthly dive into the business and science of drug development. Conversations with CEOs and BioWorld analysts in the past 12 months have included a wide range of chats with experts who are shaping the future.